Abstract
Objective
To describe the prevalence of obesity and sarcopenia among survivors of childhood acute lymphoblastic leukemia (ALL) using DEXA scan, and study associated risk factors.
Methods
This case control study was conducted between July, 2013 and June, 2014 at a tertiary care cancer centre in India. Study participants included 65 survivors of childhood ALL who were <18 years of age at diagnosis, treated between years 1996 and 2008, and were at least two years since completion of therapy. The controls included 50 matched siblings. Dual energy X-ray absorptiometry (DEXA) was used to study the body composition (body fat percentage, BF% and lean body mass, LBM) of the participants and controls. McCarthys body fat reference data were applied and logistic regression analysis was used to study various risk factors.
Results
At a median (range) follow-up of 5 (7.217.2) years, BF% (DEXA) identified a significantly higher prevalence of obesity of 21.5% (14/65) and sarcopenic obesity (14%) among survivors as compared to the controls (0/50, P<0.001), while the prevalence of sarcopenia as detected by LBM was similar at 60% (39/65) and 56% (28/50), respectively. On multivariate analysis, age at evaluation, high-risk disease and cranial irradiation were independently associated with high likelihood of obesity, while none of the factors predicted sarcopenia.
Conclusion
High prevalence of obesity and sarcopenic obesity were observed among survivors of childhood ALL.
Keywords: Body composition, Body fat, DEXA, Lean body mass, Metabolic syndrome
Acknowledgements
Dr Uma Athale and Dr Julia Challinor in editing and proof-reading the manuscript.
Contributors
PM: data acquisition, interpretation, drafting the manuscript; GK: study design, data interpretation, reviewing and finalizing manuscript; SJ: data interpretation, reviewing manuscript; SJ: data acquisition, reviewing manuscript; AS: data analysis and interpretation, reviewing manuscript.
Funding
None
Ethical clearance
Institutional Review Board; No. RGCIRC/IRB/77/2013, dated 10 September, 2013.
Footnotes
Competing interests
None stated.
References
- 1.Tamilselvan S, Scott JX, Sneha L, Divyalakshmi J. Metabolic syndrome in childhood cancer survivors. J Clin Oncol. 2017;35:145. doi: 10.1200/JCO.2017.35.5_suppl.145. [DOI] [Google Scholar]
- 2.Chueh HW, Yoo JH. Metabolic syndrome induced by anticancer treatment in childhood cancer survivors. Ann Pediatr Endocrinol Metab. 2017;22:82–9. doi: 10.6065/apem.2017.22.2.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Barnea D, Raghunathan N, Friedman DN, Tonorezos ES. Obesity and metabolic disease after childhood cancer. Oncology (Williston Park) 2015;29:849–55. [PMC free article] [PubMed] [Google Scholar]
- 4.Commission on ending childhood obesity: Taking action on childhood obesity report. 2018;WHO/NMH/PND/ECHO/18.1.
- 5.Jain S, Jain S, Kapoor G, Virmani A, Bajpai R. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2017;64. [DOI] [PubMed]
- 6.World Health Organization. World Health Organization Child Growth Standards. 2006. Accessed March 5, 2012. https://www.who.int/childgrowth/en/
- 7.Krebs NF, Himes JH, Jacobson D, et al. Assessment of child and adolescent overweight and obesity. Pediatrics. 2007;120:S193–228. doi: 10.1542/peds.2007-2329D. [DOI] [PubMed] [Google Scholar]
- 8.McCarthy HD, Cole TJ, Fry T, Jebb SA, Prentice AM. Body fat reference curves for children. Int J Obes (Lond) 2006;30:598–602. doi: 10.1038/sj.ijo.0803232. [DOI] [PubMed] [Google Scholar]
- 9.Ogden CL, Li Y, Freedman DS, Borrud LG, Flegal KM. Smoothed percentage body fat percentiles for U.S. children and adolescents, 19992004. Natl Health Stat Report. 2011;17. [PubMed]
- 10.Karlage RE, Wilson CL, Zhang N, et al. Validity of anthropometric measurements for characterizing obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study. Cancer. 2015;121:2036–43. doi: 10.1002/cncr.29300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Marriott CJC, Beaumont LF, Farncombe TH, et al. Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity. Cancer. 2018;124:1225–31. doi: 10.1002/cncr.31191. [DOI] [PubMed] [Google Scholar]
- 12.Prasad M, Arora B, Chinnaswamy G, et al. Nutritional status in survivors of childhood cancer: Experience from Tata Memorial Hospital, Mumbai. Indian J Cancer. 2015;52:219–23. doi: 10.4103/0019-509X.175814. [DOI] [PubMed] [Google Scholar]
- 13.Mohapatra S, Bansal D, Bhalla AK, et al. Is there an increased risk of metabolic syndrome among childhood acute lymphoblastic leukemia survivors? A developing country experience. Pediatr Hematol Oncol. 2016;33:136–49. doi: 10.3109/08880018.2016.1152335. [DOI] [PubMed] [Google Scholar]
- 14.Blijdorp K, van den Heuvel-Eibrink MM, Pieters R, et al. Obesity is underestimated using body mass index and waist-hip ratio in long-term adult survivors of childhood cancer. PLoS One. 2012;7:e43269. doi: 10.1371/journal.pone.0043269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Orgel E, Mueske NM, Sposto R, et al. Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy. Leuk Lymphoma. 2018;59:138–45. doi: 10.3109/10428194.2015.1136741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Rayar M, Webber CE, Nayiager T, Sala A, Barr RD. Sarcopenia in children with acute lymphoblastic leukemia. J PediatrHematol Oncol. 2013;35:98–102. doi: 10.1097/MPH.0b013e318279eea2. [DOI] [PubMed] [Google Scholar]
- 17.Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26:4639–45. doi: 10.1200/JCO.2008.16.3527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Withycombe JS, Post-White JE, Meza JL, et al. Weight patterns in children with higher risk ALL: A report from the Childrens Oncology Group (COG) for CCG 1961. Pediatr Blood Cancer. 2009;53:1249–54. doi: 10.1002/pbc.22237. [DOI] [PMC free article] [PubMed] [Google Scholar]